INS and metabolic syndrome: According to the latest update (2021) [6] on the pathophysiology and management of metabolic syndrome, it represents a group of metabolic abnormalities, including abdominal obesity, impaired insulin sensitivity, high blood pressure, and atherogenic dyslipidemia.